Active Research Studies: Renal Cancer

Comprehensive Cancer Centers is currently running the following Phase II and Phase III clinical research studies for renal cancer:

A Phase 3 Randomized Open Label Study to Compare NKTR-214 Combined with Nivolumab to the Investigator’s Choice of Sunitinib or Cabozantinib in Patients with Previously Untreated Advanced Renal Cell Carcinoma
Study#: i2704 Phase III
Contact Us: For information about this clinical study, Email Us, or use our form field.

A Phase III, Multicenter, Randomized, Open-Label Study To Evaluate The Efficacy And Safety Of Atezolizumab Given In Combination With Cabozantinib Versus Cabozantinib Alone In Patients With Inoperable, Locally Advanced, Or Metastatic Renal Cell Carcinoma Who Experienced Radiographic Tumor Progression During Or After Immune Checkpoint Inhibitor Treatment
Study#: 19236 Phase III
Contact Us: For information about this clinical study, Email Us, or use our form field.